Cisatracurium Besylate Injection
Product Images NDC 72785-0008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 72785-0008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image10 (5373d7c7 B9b5 4f82 9146 1bf722785f8a 04)

Image10 (5373d7c7 B9b5 4f82 9146 1bf722785f8a 04)
Label for cisatracurium besylate injection, USP, 10 mg/5 mL (2 mg/mL) intravenous solution. Contains storage instructions to refrigerate at 2° to 8°C and protect from light. The vial is preservative free, labeled as a 5 mL single-dose vial, manufactured by Zydus Lifesciences Limited, with a warning that it is a paralyzing agent that causes respiratory arrest and requires immediate availability for artificial respiration.*
FDA Label Image

Image11 (5373d7c7 B9b5 4f82 9146 1bf722785f8a 05)

Image11 (5373d7c7 B9b5 4f82 9146 1bf722785f8a 05)
Label for Cisatracurium Besylate Injection, USP 10 mg/mL (200 mg/20 mL) single-dose vial by Zydus Lifesciences Limited. The label includes storage instructions (refrigerate at 2° to 8°C), a warning about respiratory arrest risk, and notes it is preservative-free for intravenous use. It is intended for ICU use only with lot and expiration date fields.*
FDA Label Image

Image12 (5373d7c7 B9b5 4f82 9146 1bf722785f8a 06)

Image12 (5373d7c7 B9b5 4f82 9146 1bf722785f8a 06)
Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) intravenous injection packaging label by Zydus Lifesciences Limited. The label indicates a preservative-free formulation, supplied as 10 single-dose vials of 5 mL each. Includes warning and storage instructions, NDC 72785-0008-6, and barcode.*
FDA Label Image

Image13 (5373d7c7 B9b5 4f82 9146 1bf722785f8a 07)

Image13 (5373d7c7 B9b5 4f82 9146 1bf722785f8a 07)
Packaging label for cisatracurium besylate injection USP 200 mg/20 mL (10 mg/mL) by Zydus Lifesciences Limited. The label indicates intravenous use, single-dose vials, preservative-free, for ICU use only, with 10 vials per package. It includes manufacturer details and storage instructions visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.